Potentially giving spend management software maker Ariba Inc. a run for its money, sourcing software provider Emptoris Inc. announced on Monday the acquisition of Zeborg Inc.
Like Ariba, which has its roots in procurement, Zeborg develops spend analytics software. Zeborg brings a focus on indirect spending to Emptoris, which has a fairly strong customer base in manufacturing where there is a need for tools to deal with procurement of goods used directly in production.
The terms of the deal were undisclosed.
With the acquisition of New York-based Zeborg, Emptoris will essentially double its revenue base, bringing its customer list to about 50 companies. With that, Emptoris will be positioned as one of the largest strategic sourcing software providers in the industry, according to Avner Schneur, president and CEO of Emptoris, in Burlington, Mass. With Zeborgs focus on retail and financial services, the acquisition will also give Emptoris inroads to new vertical markets. Zeborgs ExpenseMap software is utilized in financial services companies.
Zeborg also brings with it a strong customer base from a number of industries, including seven of the worlds largest banking and financial services companies the likes of American Express, Cigna, Fleet Boston Financial Corp., and KeySpan.
Emptoris is planning a tight product integration between its line of sourcing software and Zeborgs spend management software, to be completed over the next few months. The integration will enable users to identify and prioritize sourcing savings opportunities, develop best practice strategies for savings, execute sourcing activities designed to reduce costs, and track compliancy to corporate sourcing goals and policies, officials said. At the same time, an expanded development group should bring some new technologies to market.
Emptoris Sourcing Portfolio software identifies and prioritizes sourcing savings opportunities and tracks contract compliance and supplier performance. The companys customers include American Express, Boeing, Cigna,, GlaxoSmithKline, and Motorola.